ImmuCision BioTherapeutics Receives Quick Financial Backing, Locates in University of Maryland BioPark
Published 9/5/18 on PR Newswire BALTIMORE, Sept. 5, 2018 /PRNewswire/ — The University of Maryland (UM) BioPark and UM Ventures announced today that ImmuCision BioTherapeutics (ICBT), a UM, Baltimore startup company specializing in immunotherapy, has established offices and laboratory space in the BioPark. ICBT, which commercializes and develops dendritic cell …
